Literature review on Kalarchi - Caesalpinia bonduc (L.) Roxb

Authors

  • V. Vetriselvi
  • P. Bharathajothi

Abstract

Abstract

Kalarchi is one of the Siddha drug traditionally being in use since ancient times to treat Poly Cystic Ovarian Syndrome (PCOS). The botanical name of Kalarchi is Caesalpinia bonduc (L.) Roxb is belonging to the family Caesalpiniaceae. It is a climber up to 15 m long, throughout India, near sea-coast, especially all over Bengal, Bombay and whole of Southern India. Poly Cystic Ovarian Syndrome is the highly prevalence disease among larger populations of women especially in India. Our changing lifestyle pattern is the major reason for the cause of this condition in women. Irregularities in menstrual cycle, unwanted excess hair growth, obesity are majorly seen nowadays in women’s with PCOS. Though so many therapies, treatment modalities are available in allopathic medical system, the significance of Siddha medicine is a fantastic thing in the management of PCOS in women. This review analyses the available existing literature evidences regarding the medicinal importance of Siddha drug Kalarchi. Hope this article might be highly useful for further preclinical and clinical research works which is aiming the remedy for PCOS using Siddha drug Kalarchi.

Keywords: Kalarchi, Photochemistry, Pharmacology, Microbiology, Ethno botany, Therapeutic action, Medicinal properties

Cite this Article
V.Vetriselvi, P. Bharathajothi. Literature review on Kalarchi-Caesalpinia bonduc (L.) Roxb. Research & Reviews: A Journal of Unani, Siddha and Homeopathy . 2020; 9(1): 7–11p.

Downloads

Published

2020-06-02

Issue

Vol. 7 No. 1 (2020)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.